Almost 2/3rd of patients with breast cancer have breast cancer cells positive with hormone receptors. In the adjuvant or in the metastatic breast cancer setting, a detailed discussion is usually held by the treating physician to explain the anti-estrogen therapy. The medical information sheets on such treatments given to these patients provide useful information about the name and the side effects but do not provide the rationale, mechanism of action and the benefit of these treatments over a long interval of time. This App is designed to bridge this gap of information; in the pictorial format (a picture is better than thousand words). In addition, the App aims to keep this education session individualized and simple to understand.
All information, contents and format have been provided by LRCP while technical designing and development has been completed by Canris.